Journals / Meandros Medical And Dental Journal / 2021 / Cilt: 22 - Sayı: 1

Effect of Non-surgical Periodontal Treatment on Gingival Crevicular Fluid Interleukin-1beta and Interleukin-37 in Different Periodontal Diseases

Farklı Periodontal Hastalıklarda Cerrahisiz Periodontal Tedavinin DişEti Oluğu Sıvısı İnterlökin-1beta ve İnterlökin-37 Üzerine Etkisi

Pages
110–118
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Both periodontitis groups exhibited significant improvement in clinical parameters (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Interleukin-37 (IL-37), which is a natural inhibitor of innate immunity, is correlated with chronic inflammation and some autoimmune diseases.
📊
Key Findings & Data:Proinflammatory cytokines, for example, interleukin-1beta (IL-1β), which plays a key part in the periodontium, can induce IL-37.
💡
Conclusion & Impact:Results: Both periodontitis groups exhibited significant improvement in clinical parameters (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Interleukin-37 (IL-37), which is a natural inhibitor of innate immunity, is correlated with chronic inflammation and some autoimmune diseases. Proinflammatory cytokines, for example, interleukin-1beta (IL-1β), which plays a key part in the periodontium, can induce IL-37. This study aimed to investigate the effect of non-surgical periodontal treatment on gingival crevicular fluid (GCF) IL37 and IL-1β levels in generalized aggressive periodontitis (G-AgP) and generalized chronic periodontitis (GCP). Materials and Methods: Thirty-five patients with G-AgP, 30 patients with GCP and 30 volunteers with healthy periodontal status (C) were included in this research. Patient groups received scaling and root planning with periodontal hand instrumentations. Clinical periodontal parameters and GCF samples were collected at baseline and at six weeks following SRP. Biomarker levels in GCF were analysed by enzyme-linked immunosorbent assay. Results: Both periodontitis groups exhibited significant improvement in clinical parameters (p

Özet

Amaç: Doğal bağışıklığın doğal bir inhibitörü olan interlökin-37 (IL-37), kronik enflamasyon ve bazı otoimmün hastalıklarla ilişkilidir. Periodonsiyumda önemli bir rol oynayan IL-1beta (IL-1β) gibi pro-enflamatuvar sitokinler, IL-37’yi indükleyebilir. Bu araştırmada, cerrahi olmayan periodontal tedavinin generalize agresif (G-AgP) ve generalize kronik periodontitiste (GCP) diş eti oluğu sıvısı (DOS) IL-37 ve IL-1β düzeyleri üzerine etkilerinin araştırılması amaçlanmıştır. Gereç ve Yöntemler: Otuz beş G-AgP hastası, 30 GCP hastası ve 30 periodontal olarak sağlıklı gönüllü (C) çalışmaya dahil edildi. Hasta gruplarına periodontal el aletleri ile detertraj ve kök yüzeyi düzleştirmesi uygulandı. Klinik periodontal parametrelerin ve DOS örneklerinin toplanması başlangıçta ve tedaviden 6 hafta sonra gerçekleştirildi. DOS’daki biyobelirteç seviyeleri enzim bağlı immünosorbent deneyi ile analiz edildi. Bulgular: Her iki periodontitis grubu da klinik parametrelerde anlamlı düzelme gösterdi (p

🔖

Cite This Article

TOKER, H., POYRAZ, Ö., GÖRGÜN, E. P. (2022). Effect of Non-surgical Periodontal Treatment on Gingival Crevicular Fluid Interleukin-1beta and Interleukin-37 in Different Periodontal Diseases. Meandros Medical And Dental Journal, Cilt: 22 - Sayı: 1, 110–118. https://ajindex.com/articles/578941

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Dentino A, Lee S, Mailhot J, Hefti AF. Principles of periodontology. Periodontol 2000. 2013; 61: 16-53
  2. Hasan A, Palmer R. A clinical guide to periodontology: Pathology of periodontal disease. Br Dent J 2014; 216: 457-61
  3. Nędzi-Gora M, Kowalski J, Gorska R. The immune response in periodontal tissues. Arch Immunol Ther Exp (Warsz) 2017; 65: 421-9
  4. Bosshardt DD. The periodontal pocket: pathogenesis, histopathology and consequences. Periodontol 2000. 2018; 76: 43-50
  5. Henderson B, Kaiser F. Bacterial modulators of bone remodeling in the periodontal pocket. Periodontol 2000 2018; 76: 97-108
  6. Zein Elabdeen HR, Mustafa M, Ali R, Bolstad AI. Cytokine profile in gingival crevicular fluid and plasma of patients with aggressive periodontitis. Acta Odontol Scand 2017; 75: 616-22
  7. Gilowski L, Wiench R, Plocica I, Krzeminski TF. Amount of interleukin-1β and interleukin-1 receptor antagonist in periodontitis and healthy patients. Arch Oral Biol 2014; 59: 729-34
  8. Al‐Shammari KF, Giannobile WV, Aldredge WA, Iacono VJ, Eber RM, Wang HL, et al. Effect of non‐surgical periodontal therapy on C‐telopeptide pyridinoline cross‐links (ICTP) and interleukin‐1 levels. J. J Periodontol 2001; 72: 1045-51
  9. Faizuddin M, Bharathi S, Rohini N. Estimation of interleukin‐1β levels in the gingival crevicular fluid in health and in inflammatory periodontal disease. J Periodontal Res 2003; 38: 111-4
  10. Hou LT, Liu CM, Rossomando EF. Crevicular interleukin‐1β in moderate and severe periodontitis patients and the effect of phase I periodontal treatment. J Clin Periodontol 1995; 22: 162-7
  11. Engebretson SP, Grbic JT, Singer R, Lamster IB. GCF IL‐1β profiles in periodontal disease. J Clin Periodontol 2002; 29: 48-53
  12. Reinhardt RA, Stoner JA, Golub LM, Lee HM, Nummikoski PV, Sorsa T, et al. Association of gingival crevicular fluid biomarkers during periodontal maintenance with subsequent progressive periodontitis. J Periodontol 2010; 81: 251-9
  13. Toker H, Poyraz O, Eren K. Effect of periodontal treatment on IL‐1β, IL‐1ra, and IL‐10 levels in gingival crevicular fluid in patients with aggressive periodontitis. J Clin Periodontol 2008; 35: 507-13
  14. Rosalem W, Rescala B, Teles R, Fischer R, Gustafsson A, Figueredo C. Effect of non‐surgical treatment on chronic and aggressive periodontitis: clinical, immunologic, and microbiologic findings. J Periodontol 2011; 82: 979-89
  15. Wang L, Quan Y, Yue Y, Heng X, Che F. Interleukin-37: A crucial cytokine with multiple r